Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD

E-ISSN： 1873-4286|19|29|5280-5296

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.29, 2013-09, pp. : 5280-5296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?

By Cheang Kai I Nestler John E

Reproductive BioMedicine Online, Vol. 8, Iss. 4, 2004-04 ,pp. : 440-447

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

The Role of Lifestyle Change in the Prevention and Treatment of NAFLD

Current Pharmaceutical Design, Vol. 19, Iss. 29, 2013-09 ,pp. : 5270-5279

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

By Katsiki Niki Georgiadou Eleni Hatzitolios Apostolos I.

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1417-1431

Adis International

Access to resources Recommend Favorite

Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose–insulin homeostasis and lipid metabolism

By Melkersson K. Dahl M.-L. Hulting A.-L.

Psychopharmacology, Vol. 175, Iss. 1, 2004-08 ,pp. : 1-6

Springer Publishing Company

Access to resources Recommend Favorite

Novel Drugs for the Prevention and Treatment of Acute GVHD

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1962-1973

Bentham Science Publishers

Access to resources Recommend Favorite